The 2020 update highlights the importance of accurate diagnosis of upper tract urothelial carcinoma, risk stratification, close follow-up of patients receiving kidney-sparing management, and other key aspects of care.
Patients who underwent ureteroscopic management of low-risk UTUC had a 5-year cancer-specific survival rate of 92.6%.
Overall and disease-free survival among patients undergoing surgical resection for MIUC is low despite increasing use of neoadjuvant chemotherapy.
In a study, modified Glasgow prognostic score predicted nonorgan-confined disease and lymph node invasion at surgery.
The grade-to-grade match between URS biopsy and final pathology was 66% for low-grade and 97% for high-grade tumors , according to a recent systematic review and meta-analysis.
In a large case series, stage IV disease at diagnosis and 3 or more metastatic sites were both associated with worse prognosis.
A study of 13,438 patients with upper tract urothelial carcinoma in The Netherlands found that the incidence of the cancer increased significantly from 1993 to 2017, with no improvement in survival except for those with metastatic disease.
A team of investigators from the University of Texas MD Anderson Cancer Center assessed whether a relationship exists between hepatitis C virus infection and common genitourinary cancers, such as kidney and prostate cancer.
Template-based lymph node dissection in patients with upper tract urothelial carcinoma could facilitate better local disease control by eliminating micrometastasis, according to investigators.
Investigators performed a literature review to better understand how delays in treatment might affect clinical outcomes in urologic cancer patients, including the risk of upstaging, recurrence, and mortality.